Advertisement
ASTH vs UHS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASTH is a Buy and UHS is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ASTH’s FA Score shows that 1 FA rating(s) are green whileUHS’s FA Score has 1 green FA rating(s).
- ASTH’s FA Score: 1 green, 4 red.
- UHS’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ASTH’s TA Score shows that 5 TA indicator(s) are bullish while UHS’s TA Score has 3 bullish TA indicator(s).
- ASTH’s TA Score: 5 bullish, 3 bearish.
- UHS’s TA Score: 3 bullish, 5 bearish.
Price Growth
ASTH (@Hospital/Nursing Management) experienced а +10.95% price change this week, while UHS (@Hospital/Nursing Management) price change was +0.97% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -0.69%. For the same industry, the average monthly price growth was +3.32%, and the average quarterly price growth was +4.03%.
Reported Earning Dates
ASTH is expected to report earnings on Feb 19, 2026.
UHS is expected to report earnings on Mar 04, 2026.
Industries' Descriptions
@Hospital/Nursing Management (-0.69% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
| ASTH | UHS | ASTH / UHS | |
| Capitalization | 1.26B | 14.2B | 9% |
| EBITDA | 108M | 2.58B | 4% |
| Gain YTD | -20.330 | 26.981 | -75% |
| P/E Ratio | 132.21 | 10.81 | 1,223% |
| Revenue | 2.9B | 17B | 17% |
| Total Cash | 463M | 113M | 410% |
| Total Debt | 1.09B | 5.11B | 21% |
ASTH | UHS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 21 | 65 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 85 Overvalued | 19 Undervalued | |
PROFIT vs RISK RATING 1..100 | 93 | 41 | |
SMR RATING 1..100 | 89 | 45 | |
PRICE GROWTH RATING 1..100 | 60 | 46 | |
P/E GROWTH RATING 1..100 | 3 | 63 | |
SEASONALITY SCORE 1..100 | 17 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
UHS's Valuation (19) in the Hospital Or Nursing Management industry is significantly better than the same rating for ASTH (85) in the null industry. This means that UHS’s stock grew significantly faster than ASTH’s over the last 12 months.
UHS's Profit vs Risk Rating (41) in the Hospital Or Nursing Management industry is somewhat better than the same rating for ASTH (93) in the null industry. This means that UHS’s stock grew somewhat faster than ASTH’s over the last 12 months.
UHS's SMR Rating (45) in the Hospital Or Nursing Management industry is somewhat better than the same rating for ASTH (89) in the null industry. This means that UHS’s stock grew somewhat faster than ASTH’s over the last 12 months.
UHS's Price Growth Rating (46) in the Hospital Or Nursing Management industry is in the same range as ASTH (60) in the null industry. This means that UHS’s stock grew similarly to ASTH’s over the last 12 months.
ASTH's P/E Growth Rating (3) in the null industry is somewhat better than the same rating for UHS (63) in the Hospital Or Nursing Management industry. This means that ASTH’s stock grew somewhat faster than UHS’s over the last 12 months.
| ASTH | UHS | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 80% | 2 days ago 51% |
| Stochastic ODDS (%) | 2 days ago 82% | 2 days ago 58% |
| Momentum ODDS (%) | 2 days ago 78% | 2 days ago 67% |
| MACD ODDS (%) | 2 days ago 86% | 2 days ago 52% |
| TrendWeek ODDS (%) | 2 days ago 81% | 2 days ago 68% |
| TrendMonth ODDS (%) | 2 days ago 78% | 2 days ago 68% |
| Advances ODDS (%) | 2 days ago 79% | 21 days ago 72% |
| Declines ODDS (%) | 16 days ago 73% | 16 days ago 65% |
| BollingerBands ODDS (%) | N/A | 2 days ago 62% |
| Aroon ODDS (%) | 2 days ago 77% | 2 days ago 65% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GCEDX | 11.26 | 0.03 | +0.27% |
| Goldman Sachs Clean Energy Income Ins | |||
| TGADX | 28.56 | 0.06 | +0.21% |
| Templeton Growth Adv | |||
| GGESX | 24.93 | 0.05 | +0.20% |
| Nationwide Schroders Global Eq Instl Svc | |||
| MCSPX | 11.63 | 0.02 | +0.17% |
| BlackRock Advantage SMID Cap Inv C | |||
| FCCVX | 39.71 | N/A | N/A |
| Fidelity Advisor Convertible Secs C | |||
ASTH and
Correlation & Price change
A.I.dvisor indicates that over the last year, ASTH has been loosely correlated with ACHC. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ASTH jumps, then ACHC could also see price increases.
| Ticker / NAME | Correlation To ASTH | 1D Price Change % | ||
|---|---|---|---|---|
| ASTH | 100% | +2.78% | ||
| ACHC - ASTH | 48% Loosely correlated | +1.42% | ||
| DCGO - ASTH | 39% Loosely correlated | +4.04% | ||
| PNTG - ASTH | 31% Poorly correlated | -0.44% | ||
| UHS - ASTH | 31% Poorly correlated | -0.08% | ||
| HCA - ASTH | 30% Poorly correlated | +0.00% | ||
More | ||||
UHS and
Correlation & Price change
A.I.dvisor indicates that over the last year, UHS has been closely correlated with HCA. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if UHS jumps, then HCA could also see price increases.
| Ticker / NAME | Correlation To UHS | 1D Price Change % | ||
|---|---|---|---|---|
| UHS | 100% | -0.08% | ||
| HCA - UHS | 78% Closely correlated | +0.00% | ||
| THC - UHS | 69% Closely correlated | -0.50% | ||
| ENSG - UHS | 59% Loosely correlated | -1.09% | ||
| ACHC - UHS | 54% Loosely correlated | +1.42% | ||
| CON - UHS | 52% Loosely correlated | +0.61% | ||
More | ||||